Global Retirement Partners’s Maravai LifeSciences MRVI Stock Holding History

Global Retirement Partners’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23K	Buy	+197	New	+$850	﹤0.01%	4157
2025 Q4	$328	Buy	+101	New	+$340	﹤0.01%	4058
2024 Q4	$414	Sell	76 -103	-58%	-$663	﹤0.01%	3433
2024 Q3	$1.49K	Hold	179	–	–	﹤0.01%	3032
2024 Q2	$1.28K	Hold	179	–	–	﹤0.01%	3102
2024 Q1	$1.55K	Buy	179 +66	+58%	+$447	﹤0.01%	2841
2023 Q4	$727	Sell	113 -57	-34%	-$368	﹤0.01%	2980
2023 Q3	$1.64K	Buy	170 +17	+11%	+$187	﹤0.01%	2606
2023 Q2	$1.9K	Buy	153 +69	+82%	+$931	﹤0.01%	2569
2023 Q1	$1.12K	Buy	84 +61	+265%	+$876	﹤0.01%	2700
2022 Q4	$329	Hold	23	–	–	﹤0.01%	2850
2022 Q3	$0	Buy	+23	New	+$577	﹤0.01%	2875

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Global Retirement Partners's MRVI Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 197 shares worth $1.23K. The stake represents ﹤0.01% of the portfolio and ranks #4157 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in MRVI as recently as Q4 2025.

Global Retirement Partners first reported a position in MRVI in Q3 2022 and has held it in 12 quarters since. The position peaked at $1.9K in Q2 2023. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Global Retirement Partners held 197 shares of Maravai LifeSciences worth $1.23K as of Q2 2026.
Maravai LifeSciences was a new Global Retirement Partners position in Q2 2026.
Maravai LifeSciences made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4157 holding.
Global Retirement Partners first reported a position in Maravai LifeSciences in Q3 2022 and has held it in 12 quarters since.
Global Retirement Partners's Maravai LifeSciences position peaked at $1.9K in Q2 2023.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.